JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CALL
Ecolab
ECL
$77.4B
| $6.67M | ﹤0.01% |
34,700
| – | – |
|
|
BFIN
2327
DELISTED
BankFinancial
BFIN
| $6.67M | ﹤0.01% |
482,247
+48,282
| +11% | +$701K |
|
|
NBL
2328
DELISTED
Noble Energy, Inc.
NBL
| $6.66M | ﹤0.01% |
305,356
+9,022
| +3% | +$214K |
|
2329
ZTO Express
ZTO
$17.4B
| $6.65M | ﹤0.01% |
346,393
-565,397
| -62% | -$10.6M |
|
2330
Signet Jewelers
SIG
$3.6B
| $6.65M | ﹤0.01% |
375,925
+195,390
| +108% | +$4.2M |
|
2331
Columbus McKinnon
CMCO
$550M
| $6.63M | ﹤0.01% |
161,162
+2,801
| +2% | +$107K |
|
2332
PUT
Kroger
KR
$35.1B
| $6.63M | ﹤0.01% |
310,000
| – | – |
|
|
KBAL
2333
DELISTED
Kimball International
KBAL
| $6.58M | ﹤0.01% |
388,298
+191,209
| +97% | +$3.02M |
|
2334
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $6.58M | ﹤0.01% |
142,216
-30,840
| -18% | -$1.43M |
|
2335
PUT
Enterprise Products Partners
EPD
$82.1B
| $6.58M | ﹤0.01% |
229,800
+79,800
| +53% | +$2.3M |
|
2336
PUT
TJX Companies
TJX
$170B
| $6.56M | ﹤0.01% |
124,100
+69,100
| +126% | +$3.67M |
|
2337
CALL
Sanofi
SNY
$105B
| $6.56M | ﹤0.01% |
152,200
+60,000
| +65% | +$2.55M |
|
|
2338
PUT
Sanofi
SNY
$105B
| $6.56M | ﹤0.01% |
152,200
+60,000
| +65% | +$2.55M |
|
2339
Vanguard Extended Market ETF
VXF
$32.3B
| $6.53M | ﹤0.01% |
55,713
-293
| -0.5% | -$34.2K |
|
|
SFIX
2340
Stitch Fix
SFIX
$487M
| $6.52M | ﹤0.01% |
214,252
+92,963
| +77% | +$2.49M |
|
|
VRN
2341
DELISTED
Veren
VRN
| $6.51M | ﹤0.01% |
1,966,569
+625,987
| +47% | +$2.25M |
|
2342
Crocs
CROX
$6.36B
| $6.51M | ﹤0.01% |
331,677
-136,143
| -29% | -$3.15M |
|
|
BPMC
2343
PUT
DELISTED
Blueprint Medicines
BPMC
| $6.49M | ﹤0.01% |
+70,000
| New | +$5.78M |
|
2344
B2Gold
BTG
$6.7B
| $6.49M | ﹤0.01% |
2,183,950
+1,597,044
| +272% | +$4.37M |
|
|
2345
PUT
Occidental Petroleum
OXY
$57.7B
| $6.47M | ﹤0.01% |
130,000
+100,000
| +333% | +$5.63M |
|
2346
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
| $6.45M | ﹤0.01% |
134,028
+14,730
| +12% | +$703K |
|
2347
HealthStream
HSTM
$849M
| $6.45M | ﹤0.01% |
247,694
+113,684
| +85% | +$2.99M |
|
2348
Pediatrix Medical
MD
$2.14B
| $6.45M | ﹤0.01% |
262,102
-19,374
| -7% | -$520K |
|
|
EPZM
2349
DELISTED
Epizyme, Inc
EPZM
| $6.45M | ﹤0.01% |
528,411
+79,251
| +18% | +$1.02M |
|
2350
ICL Group
ICL
$6.96B
| $6.44M | ﹤0.01% |
1,240,956
-724,158
| -37% | -$3.83M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.